Medical Polymer Splint Market

The polymer splint has high hardness and light weight, which reduces the load on the functional exercise after fixation, is conducive to blood circulation and promotes healing. A series of new external fixing materials and technical applications, especially splints made of synthetic materials, such as: glass fiber splint, polyurethane splint, resin splint, inflatable splint, etc. These splints have been significantly improved in terms of materials, manufacturing processes and flexible application of mechanical principles, and have received good therapeutic effects in the clinic.
Medical Polymer Splint Market contains market size and forecasts of Medical Polymer Splint in global, including the following market information:
Global Medical Polymer Splint Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Medical Polymer Splint Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Medical Polymer Splint companies in 2021 (%)
The global Medical Polymer Splint market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Glass fiber Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Medical Polymer Splint include Glaxsan Pharma, Tuoren, Performance Health, Topcare Biotech, AdvaCare Pharma, Jiangsu Maibang Biotechnology, Shandong Haidi Ke Biotechnology, Shaanxi Yuanguang High Technology and Jinan Tasite Biotechnology, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Medical Polymer Splint manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Polymer Splint Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Polymer Splint Market Segment Percentages, by Type, 2021 (%)
Glass fiber
Polyurethane
Resin
Other
Global Medical Polymer Splint Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Polymer Splint Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinical
Other
Global Medical Polymer Splint Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Medical Polymer Splint Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Polymer Splint revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Medical Polymer Splint revenues share in global market, 2021 (%)
Key companies Medical Polymer Splint sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Medical Polymer Splint sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glaxsan Pharma
Tuoren
Performance Health
Topcare Biotech
AdvaCare Pharma
Jiangsu Maibang Biotechnology
Shandong Haidi Ke Biotechnology
Shaanxi Yuanguang High Technology
Jinan Tasite Biotechnology
Anhui Ankang Health Materials
Wuxi S&Y